123 related articles for article (PubMed ID: 1724984)
1. Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Yang WC; Chiang SS; Huang TP
J Med Virol; 1991 Dec; 35(4):263-6. PubMed ID: 1724984
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
Chan TM; Lok AS; Cheng IK
Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
Huang CC; Wu MS; Lin DY; Liaw YF
Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
[TBL] [Abstract][Full Text] [Related]
4. Environmental transmission of hepatitis B and hepatitis C viruses within the hemodialysis unit.
Cendoroglo Neto M; Manzano SI; Canziani ME; Silva AE; Cirenza LF; Sesso Rde C; Ajzen H; Draibe SA
Artif Organs; 1995 Mar; 19(3):251-5. PubMed ID: 7539998
[TBL] [Abstract][Full Text] [Related]
5. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission.
Cendoroglo Neto M; Draibe SA; Silva AE; Ferraz ML; Granato C; Pereira CA; Sesso RC; Gaspar AM; Ajzen H
Nephrol Dial Transplant; 1995; 10(2):240-6. PubMed ID: 7538651
[TBL] [Abstract][Full Text] [Related]
6. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
[TBL] [Abstract][Full Text] [Related]
7. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis.
Ng YY; Lee SD; Wu SC; Liu WT; Chia WL; Huang TP
Perit Dial Int; 1993; 13(2):132-5. PubMed ID: 7684259
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies against hepatitis C virus in a dialysis unit.
Cantù P; Mangano S; Masini M; Limido A; Crovetti G; DeFilippo C
Nephron; 1992; 61(3):337-8. PubMed ID: 1323784
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.
Lee HY; Kang DH; Park CS; Kim KY; Kang SW; Kim HS; Choi KH; Ha SK; Han DS
Yonsei Med J; 1993 Dec; 34(4):371-80. PubMed ID: 7510444
[TBL] [Abstract][Full Text] [Related]
10. Viral hepatitis in continuous ambulatory peritoneal dialysis patients in an endemic area for hepatitis B and C infection: the Taiwan experience.
Hung KY; Shyu RS; Huang CH; Tsai TJ; Chen WY
Blood Purif; 1997; 15(3):195-9. PubMed ID: 9262846
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in renal dialysis patients in Glasgow.
McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
[TBL] [Abstract][Full Text] [Related]
14. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
[TBL] [Abstract][Full Text] [Related]
15. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis.
Castelnovo C; Sampietro M; De Vecchi A; Corbetta N; Cantù M; Orlandi A; Lunghi G; Ponticelli C
Nephrol Dial Transplant; 1997 May; 12(5):978-80. PubMed ID: 9175053
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors for hepatitis C virus infection in continuous ambulatory peritoneal dialysis patients.
Górriz JL; Miguel A; García-Ramón R; Pérez-Contreras J; Olivares J; Gómez-Roldán C; Alvariño J; Lanuza M
Nephrol Dial Transplant; 1996 Jun; 11(6):1109-12. PubMed ID: 8671977
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis-C virus (HCV) in peritoneal dialysis.
Krautzig S; Tillmann H; Wrenger E; Manns M; Koch KM; Brunkhorst R
Clin Nephrol; 1994 Feb; 41(2):120. PubMed ID: 7516274
[No Abstract] [Full Text] [Related]
20. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
